206 filings
Page 3 of 11
8-K
GSTC
GlobeStar Therapeutics Corp
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
10-Q
2021 Q1
GSTC
GlobeStar Therapeutics Corp
Quarterly report
28 Jan 21
2:17pm
8-K
GSTC
GlobeStar Therapeutics Corp
22 Dec 20
Regulation FD Disclosure
5:14pm
8-K
GSTC
GlobeStar Therapeutics Corp
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
10-K
2020 FY
GSTC
GlobeStar Therapeutics Corp
Annual report
3 Dec 20
4:46pm
3
GSTC
GlobeStar Therapeutics Corp
13 Oct 20
AngioSoma / JAMES C KATZAROFF ownership change
2:17pm
4/A
GSTC
GlobeStar Therapeutics Corp
25 Aug 20
AngioSoma / Alex K Blankenship ownership change
11:03am
8-K
GSTC
GlobeStar Therapeutics Corp
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm
8-K
GSTC
GlobeStar Therapeutics Corp
24 Aug 20
Departure of Directors or Certain Officers
4:58pm
10-Q
2020 Q3
GSTC
GlobeStar Therapeutics Corp
Quarterly report
14 Jul 20
4:09pm
10-Q
2020 Q2
GSTC
GlobeStar Therapeutics Corp
Quarterly report
5 May 20
2:57pm
SC 13D/A
GSTC
GlobeStar Therapeutics Corp
9 Mar 20
AngioSoma / Atwood Brent ownership change
12:00am
4
GSTC
GlobeStar Therapeutics Corp
28 Feb 20
AngioSoma / Brent Atwood ownership change
4:03pm
10-Q
2020 Q1
GSTC
GlobeStar Therapeutics Corp
Quarterly report
14 Feb 20
3:33pm
10-K
2019 FY
GSTC
GlobeStar Therapeutics Corp
Annual report
31 Dec 19
4:05pm
NT 10-K
GSTC
GlobeStar Therapeutics Corp
31 Dec 19
Notice of late annual filing
1:01pm
8-K
GSTC
GlobeStar Therapeutics Corp
1 Nov 19
Regulation FD Disclosure
3:55pm
8-K
GSTC
GlobeStar Therapeutics Corp
28 Oct 19
Regulation FD Disclosure
5:17pm
8-K
GSTC
GlobeStar Therapeutics Corp
23 Oct 19
AngioSoma, Inc. Announces Settlement of Litigation
11:28am
DEF 14A
GSTC
GlobeStar Therapeutics Corp
Definitive proxy
23 Sep 19
9:45pm